RxDoctor Payments Data

Karin Young

Women's Health · Pittsburgh, PANPI 1902290323

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Sumitomo Pharma America, Inc. accounts for 61.4% of it on its own, with 14 other manufacturers making up the rest. Among women's health clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,696in general payments, 2019–2025

Across 145 payments — averaging $25.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$2K
  • Myovant Sciences Inc.$514
  • Sage Therapeutics, LLC$209
  • Astellas Pharma US Inc$158
  • Lilly USA, LLC$97
  • AbbVie$91
  • plus $359 from 9 others

What the payments were for

  • Food & beverage$3,65199%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,696 in reported general payments places this provider in the 95th percentile of 250 women's health providers in Pennsylvania.

See all women's health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$2,813
Medicare patients
31
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol30$1,433

Paid to pharmacies, not to this prescriber.

Other women's health in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →